In the News

WashU Public Health’s Morgan Shields contributes to a growing body of evidence showing that for-profit psychiatric hospitals are illegally turning away patients in crisis.

The “most favored nation” policy aims to lower U.S. drug prices by matching the lowest prices paid in other wealthy countries. But recent claims of 1,000% price reductions are mathematically impossible, says WashU Public Health’s Tim McBride.

WashU Public Health’s Morgan Shields led a national survey study that reveals mixed public support for involuntary psychiatric policies. While a sizeable minority of Americans back forced treatment, majorities favor expanding community-based and peer-led services.

WashU Public Health’s Morgan Shields calls attention to systemic failures and lack of accountability in psychiatric care.

Classifying Chagas disease as endemic to the U.S. could strengthen surveillance, research and public health responses, says WashU Medicine’s Philip Budge, a secondary faculty member at SPH.

WashU Public Health’s Rodrigo Reis talked with KMOX about his study highlighting major gaps in access to healthy food and transportation — especially in north St. Louis.

Olin Business’ Patrick Aguilar, MD, a secondary faculty member at SPH, says that people who don’t meet the restricted eligibility criteria can still obtain a COVID-19 vaccine, but the increased difficulty will deter some.

A program designed to help rural hospitals stay open is inadequately funded and provides uneven assistance, says WashU Public Health’s Timothy McBride, a health policy expert.

WashU Medicine’s Patricia Cavazos-Rehg, an SPH secondary faculty member, says that although some studies showed benefits of cannabis for anxiety and depression, many studies also found risks.

WashU Public Health’s Tim McBride explains how rising hospital costs and shrinking federal health-care funding are fueling disputes between hospitals and insurers. As negotiations stall, access to care and coverage hangs in the balance.